LI:NASDAQLi Auto Inc. Analysis
Data as of 2026-06-07 - not real-time
$14.20
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Li Auto (LI) is trading at $14.20, well below its 20‑day ($16.52), 50‑day ($17.52) and 200‑day ($19.26) simple moving averages, signaling a pronounced bearish technical stance. The RSI of 29.9 places the stock in oversold territory, while a bearish MACD histogram (-0.196) and a support level at $14.06 suggest limited upside in the near term. Despite a forward P/E of 13.8 and an ultra‑low price‑to‑sales multiple of 0.13, the company posted a 11.4% revenue decline year‑over‑year, a gross margin of only 15.9% (further eroded to 7.9% in Q1 2026), and a net loss of RMB 2.3 bn, with negative operating and free cash flow. The balance sheet remains strong with $93 bn in cash versus $17.7 bn debt, but the debt‑to‑equity ratio of 25% and a 55% 30‑day volatility underscore financial strain.
The launch of the all‑new Li L9 and sustained deliveries of over 20,000 i6 units per month have reignited sales growth, with Q2 deliveries projected at 95‑100 k vehicles and May deliveries reaching 33,350 units. Analyst consensus remains bullish (27 analysts, “Buy” rating) and target prices average $18.8, implying ~32% upside. However, the sector’s cyclical nature, heightened regulatory scrutiny in China’s EV market, and the company’s ongoing margin compression temper enthusiasm. Investors should weigh the undervalued valuation against the high volatility, negative cash flows, and medium‑to‑high geographic and regulatory risks.
The launch of the all‑new Li L9 and sustained deliveries of over 20,000 i6 units per month have reignited sales growth, with Q2 deliveries projected at 95‑100 k vehicles and May deliveries reaching 33,350 units. Analyst consensus remains bullish (27 analysts, “Buy” rating) and target prices average $18.8, implying ~32% upside. However, the sector’s cyclical nature, heightened regulatory scrutiny in China’s EV market, and the company’s ongoing margin compression temper enthusiasm. Investors should weigh the undervalued valuation against the high volatility, negative cash flows, and medium‑to‑high geographic and regulatory risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support at $14.06
- Oversold RSI indicating potential short‑term bounce
- Weak profitability and negative cash flow
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Launch of the Li L9 expanding product lineup
- Improving delivery volumes (95k+ Q2 guidance)
- Undervalued valuation metrics (P/S 0.13, forward P/E 13.8)
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term growth of China’s EV market
- Strong cash position offsetting debt load
- Analyst consensus upside of ~30% to target price
Key Metrics & Analysis
Financial Health
Revenue Growth-11.40%
Profit Margin-1.66%
P/E Ratio13.8
ROE-2.50%
ROA-1.51%
Debt/Equity25.12
P/B Ratio1.4
Op. Cash Flow$-13001422848
Free Cash Flow$-15601390592
Technical Analysis
TrendBearish
RSI29.9
Support$14.06
Resistance$20.09
MA 20$16.52
MA 50$17.52
MA 200$19.26
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
Target Price$18.78
Upside/Downside32.28%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.99
Volatility50.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.